Literature DB >> 1695004

Ligand binding to the cell surface receptor for reovirus type 3 stimulates galactocerebroside expression by developing oligodendrocytes.

J A Cohen1, W V Williams, D B Weiner, H M Geller, M I Greene.   

Abstract

Viruses utilize normal cell surface structures as attachment sites. Interaction of viral components with these structures may alter target cell growth. In the present study, the expression and function of the cell surface receptor for reovirus type 3 (Reo3R) was studied in neonatal rat optic nerve glial cultures. The Reo3R is expressed by mature oligodendrocytes and astrocytes but not by O-2A progenitor cells. It appears at an early stage of oligodendrocyte development, coincident with the O4 marker but prior to galactocerebroside or myelin basic protein. Anti-Reo3R antibodies stimulate the expression of galactocerebroside by developing oligodendrocytes. Divalent Reo3R-binding peptides are similarly active. Maximal stimulation of galactocerebroside expression occurs with treatment as short as 4 hr, consistent with a receptor-mediated process. Cell surface structures used as an attachment site by reovirus type 3 may also play a role in the regulation of oligodendrocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695004      PMCID: PMC54233          DOI: 10.1073/pnas.87.13.4922

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Reovirus type 3 and [125I]-iodocyanopindolol bind to distinct domains on the beta-adrenergic like receptor.

Authors:  J Liu; M S Co; M I Greene
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

2.  Localization of beta-adrenergic receptors on differentiated cells of the central nervous system in culture.

Authors:  R Ventimiglia; M I Greene; H M Geller
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  Structural similarities between the mammalian beta-adrenergic and reovirus type 3 receptors.

Authors:  M S Co; G N Gaulton; A Tominaga; C J Homcy; B N Fields; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

4.  Reovirus type 1 and type 3 differ in their binding to isolated intestinal epithelial cells.

Authors:  D B Weiner; K Girard; W V Williams; T McPhillips; D H Rubin
Journal:  Microb Pathog       Date:  1988-07       Impact factor: 3.738

5.  Development of biologically active peptides based on antibody structure.

Authors:  W V Williams; D A Moss; T Kieber-Emmons; J A Cohen; J N Myers; D B Weiner; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

6.  Sequences of the cell-attachment sites of reovirus type 3 and its anti-idiotypic/antireceptor antibody: modeling of their three-dimensional structures.

Authors:  W V Williams; H R Guy; D H Rubin; F Robey; J N Myers; T Kieber-Emmons; D B Weiner; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

7.  A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium.

Authors:  M C Raff; R H Miller; M Noble
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

8.  Antiidiotypic antibody to reovirus binds to neurons and protects from viral infection.

Authors:  M A Dichter; H L Weiner; B N Fields; G Mitchell; J Noseworthy; G Gaulton; M Greene
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

9.  Does the beta-adrenergic receptor function as a reovirus receptor?

Authors:  A H Choi; P W Lee
Journal:  Virology       Date:  1988-03       Impact factor: 3.616

10.  Inhibition of cellular DNA synthesis by reovirus occurs through a receptor-linked signaling pathway that is mimicked by antiidiotypic, antireceptor antibody.

Authors:  G N Gaulton; M I Greene
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  2 in total

1.  Anti-reovirus receptor antibody accelerates expression of the optic nerve oligodendrocyte developmental program.

Authors:  J A Cohen; W V Williams; H M Geller; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

2.  Absence of superinfection exclusion during asynchronous reovirus infections of mouse, monkey, and human cell lines.

Authors:  N D Keirstead; K M Coombs
Journal:  Virus Res       Date:  1998-04       Impact factor: 3.303

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.